Overview

Methylphenidate Treatment of Cancer-Related Fatigue

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this randomized controlled clinical trial is to investigate the efficacy and safety of methylphenidate in patients with fatigue caused by cancer.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Medice Arzneimittel Pütter GmbH & Co KG
Treatments:
Methylphenidate